MindMed has taken a significant step forward in the development of innovative treatments for Generalised Anxiety Disorder (GAD), announcing...
Lire la suiteBeckley Psytech has unveiled promising topline results from its Phase 2a study of ELE-101, a groundbreaking synthetic intravenous (IV)...
Lire la suiteSuntory Beverage & Food GB&I (SBF GB&I), the producer of household favourites Lucozade and Ribena, has announced a transformative...
Lire la suiteMinoryx Therapeutics and Neuraxpharm Group have announced a significant breakthrough in the treatment of cerebral adrenoleukodystrophy (cALD) in paediatric...
Lire la suiteBayer has officially begun a Phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 inhibitor designed to...
Lire la suiteDudley-based pork pie maker T.C. Morris has taken a significant step forward in its journey, securing a five-figure funding...
Lire la suite